Related Experiment Video
Updated: Apr 15, 2026

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology
Published on: August 18, 2014
Association between polymorphism of β3-adrenoceptor gene and overactive bladder: a meta-analysis
1Department of Urological Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
Genetic variations in the beta-3 adrenoceptor gene are linked to overactive bladder (OAB). The Trp64Arg polymorphism increases OAB risk, with Arg allele carriers showing higher susceptibility. This finding clarifies the role of beta-3 adrenoceptor gene variations in OAB development.
Area of Science:
- Genetics
- Urology
- Pharmacology
Background:
- Genetic variations in the human beta-3 adrenoceptor (β3-AR) gene influence bladder muscle function.
- The Trp64Arg polymorphism in the β3-AR gene is implicated in overactive bladder (OAB) development.
- Previous studies on the association between this polymorphism and OAB risk have yielded controversial results.
Purpose of the Study:
- To conduct a meta-analysis to investigate the association between the β3-AR Trp64Arg polymorphism and the risk of developing overactive bladder (OAB).
Main Methods:
- A meta-analysis was performed on 2 case-control studies.
- The analysis included a total of 149 OAB cases and 270 healthy controls.
- Examined the association between the Trp64Arg polymorphism and OAB susceptibility.
Main Results:
- The Arg allele of the β3-AR gene was found to be positively associated with OAB susceptibility.
- Individuals carrying the Arg allele (Trp64Arg and Arg64Arg genotypes) showed a positive association with OAB.
- The Trp64Arg polymorphism is implicated in the pathogenesis of OAB.
Conclusions:
- The β3-AR Trp64Arg polymorphism plays a role in the development of overactive bladder.
- The Arg allele and its carriers are associated with an increased risk of OAB.
- This meta-analysis provides evidence supporting the involvement of β3-AR genetic variations in OAB pathogenesis.
Related Concept Videos
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Antihypertensive Drugs: Action of β1 Blockers
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...

